文献速递青光眼

单基因与多基因风险与开角型青光眼患病率的关联

Association of Monogenic and Polygenic Risk With the Prevalence of Open-Angle Glaucoma.
PubMed 文献 · JAMA Ophthalmol · 2021-01-01

结果显示,高多基因风险(未选择人群前5%)的青光眼风险(OR 2.77;95%CI 2.58-2.98)与MYOC p.Gln368Ter杂合子风险(OR 4.19;95%CI 3.25-5.31)相当,且高多基因风险在普通人群中比MYOC p.Gln368Ter杂合子常见15倍以上(5.0% vs 0.32%)。

要点

  • 高多基因风险(前5%)与青光眼风险增加相关,OR为2.77(95%CI 2.58-2.98)。
  • MYOC p.Gln368Ter杂合子的青光眼风险OR为4.19(95%CI 3.25-5.31)。
  • 高多基因风险在普通人群中比MYOC p.Gln368Ter杂合子常见15倍以上(5.0% vs 0.32%)。

核心结论

  • 单基因与高多基因风险均与青光眼患病风险增加2.5倍以上相关,且平均诊断年龄相当。
  • 高多基因风险在普通人群中比MYOC p.Gln368Ter杂合子常见15倍以上。

研究设计与样本

  • 英国生物银行招募于2006年至2010年进行,数据分析于2019年9月至2020年8月进行。

主要发现

  • 高多基因风险(未选择人群前5%)与青光眼风险的OR为2.77(95%CI 2.58-2.98)。
  • MYOC p.Gln368Ter杂合子与青光眼风险的OR为4.19(95%CI 3.25-5.31)。
  • ANZRAG中高多基因风险占15.7%,MYOC p.Gln368Ter杂合子占2.6%;普通人群中分别为5.0%和0.32%。
  • ANZRAG中高多基因风险者的平均(SD)诊断年龄为57.2(14.2)岁,MYOC p.Gln368Ter杂合子为54.8(13.6)岁,P > .99。

关键数值与推荐

  • 高多基因风险定义为未选择人群多基因风险评分前5%。
  • 青光眼风险以OR表示:高多基因风险OR 2.77(95%CI 2.58-2.98),MYOC p.Gln368Ter杂合子OR 4.19(95%CI 3.25-5.31)。
  • 高多基因风险在ANZRAG中占15.7%,在普通人群中占5.0%;MYOC p.Gln368Ter杂合子分别占2.6%和0.32%。
  • 平均诊断年龄(SD):高多基因风险57.2(14.2)岁,MYOC p.Gln368Ter杂合子54.8(13.6)岁,P > .99。

临床怎么用

  • 多基因风险评分可用于识别青光眼高风险个体,其风险效应与常见单基因变异相当。
  • 高多基因风险在人群中更常见,可能对风险分层有更大的人群影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Early diagnosis of open-angle glaucoma can lead to vision-saving treatment, and genetic variation is an increasingly powerful indicator in disease risk stratification. OBJECTIVE: To compare polygenic and monogenic variants in risk of glaucoma. DESIGN, SETTING, AND PARTICIPANTS: Clinical and genetic data were obtained for 2507 individuals from the Australian and New Zealand Registry of Advanced Glaucoma (ANZRAG) and 411 337 individuals in cross-sectional cohort studies including individuals of European ancestry in the UK Biobank. Recruitment to the UK Biobank occurred between 2006 and 2010, and data analysis occurred between September 2019 and August 2020. MAIN OUTCOMES AND MEASURES: Association of monogenic and polygenic variants with glaucoma risk. RESULTS: Individuals at high polygenic risk, defined as those in the top 5% of an unselected population, had a glaucoma risk (odds ratio [OR], 2.77; 95% CI, 2.58-2.98) comparable with the risk among individuals heterozygous for the MYOC p.Gln368Ter variant (OR 4.19; 95% CI, 3.25-5.31), which is the most common single-gene variant known to cause primary open-angle glaucoma. High polygenic risk was more than 6 times more common than MYOC p.Gln368Ter heterozygosity in ANZRAG (15.7% vs 2.6%) and more than 15 times more common in the general population (5.0% vs 0.32%). Within ANZRAG, high polygenic risk was associated with a mean (SD) age at glaucoma diagnosis that did not differ from the age at glaucoma diagnosis among individuals heterozygous for MYOC p.Gln368Ter (57.2 [14.2] vs 54.8 [13.6] years; P > .99). CONCLUSIONS AND RELEVANCE: Monogenic and high polygenic risk were each associated with a more than 2.5-fold increased odds of developing glaucoma and an equivalent mean age at glaucoma diagnosis, with high polygenic risk more than 15 times more common in the general population.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Siggs OM, Han X, Qassim A, et al. Association of Monogenic and Polygenic Risk With the Prevalence of Open-Angle Glaucoma. JAMA Ophthalmol. 2021. PMID: 34264281. doi:10.1001/jamaophthalmol.2021.2440

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。